High resolution multispectral retinal imaging in real time – more information with a single, immediate capture.
iCapture™45* is a non-mydriatic and mydriatic multispectral retinal imaging camera with a 45◦ field of view, powered by Spring Vision’s proprietary technology.
Multispectral imaging, combined with retinal tissue oximetry (under clinical investigation) and additional unique features of the iCapture™45, is expected to revolutionize the diagnostic ability and clinical application of retinal imaging, towards a better forecast of retinal and systemic diseases through retinal imaging.
With an exceptional combination of multispectral retinal imaging, retinal tissue oximetry and microvascular spatial visualization of the retina and choroid, iCapture™45 also offers the Layers view: a qualitative relative presentation of the defect location within the retina sphere. This dimensional reflection results in a differentiation between healthy and diseased retinal tissues.
iCapture™45 will be launched in mid-2022, to be followed by additional innovative products.
*Pending FDA clearance
Spring Vision develops a technology for non-invasive, real-time, multispectral retinal imaging for diagnosis of retinal and systemic diseases.
This proprietary technology allows physicians to better differentiate between healthy and early-stage diseased retinal blood vessels.
The unique capabilities of the iCapture™45 are expected to revolutionize the way modern-day medicine is practiced and will benefit both physicians and patients.
Safe & Accurate
Our multispectral imager, the iCapture™45, has unique capabilities to discern subtle, micron-scale changes in retinal blood vessels.
Led by experienced executives and with a team of physicians, algorithm engineers and other specialists, the company focuses on developing groundbreaking products, with emphasis on accurate real time results, a variety of new capabilities and ease of use.
Spring Vision brings the next generation of imaging systems with its uncompromising hallmark of excellence. Setting new standards, the iCapture™ Product Line is developed to suit your needs
Noam Allon | CEO
35 years of executive experience in medical imaging companies, with 10 registered patents in retinal imaging & radiology.
VP R&D & Regulation
Michal Nir | VP R&D & Regulation
Over 20 years of experience in medical imaging companies (radiology & ophthalmology) and long standing FDA experience with several medical devices.
Chief Technology Officer
Avihu Gamliel | Chief Technology Officer
Expertise in image processing, machine learning, AI, biometry and face-recognition technologies. Elsevier official reviewer in Machine Vision and Biometrics with 15 registered patents in imaging & biometry.
VP Finance & Operations
Gabi Buganim | VP Finance & Operations
Licensed CPA (IL) with over 20 years of experience in financial accounting, auditing and taxation, in Hi-tech and infrastructure companies.
VP of Global Marketing
Moran Faibish | VP of Global Marketing
15 years of experience with driving product sales and global growth in the medical field, specializing in strategic marketing processes such as product positioning, market penetration and growth hacking.
VP S&M - USA
Mark Maio | VP S&M - USA
B.Sc in Biomedical Photography, M.A. in Photography and Communication Design, Adjunct Professor of Photography in the Biomedical Photography program at Rochester Institute of Technology. Over 30 Years of experience in the field of ophthalmic imaging and a renowned imaging consultant.
Michael Belkin, MA, MD
Chief Medical Officer
Arie Orenstein, MD
Eyal Margalit, MD, PhD
Senior Clinical Researcher
Genady Kostenich, PhD
Sr. Biology Scientist
Meir (Michel) Ehrenfreund
Spring Vision LTD
8 Ha-Neviim St.,
Tel: +972 77 2009796